RELIANT GLYCOSCIENCES
Live / Applied — Statement of use — registration review complete (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 09 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98035697
- Mark type
- Stylized text
- Filed
- 09 Jun 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Tripp Watson
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic assays for testing serum levels of Gd-IgA1 biomarker present in IgA nephropathy
Owner
- Reliant Glycosciences, LLC, Birmingham, AL, US
- Reliant Glycosciences, LLC, Birmingham, AL, US
Prosecution history
- 23 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Aug 2025 — USE AMENDMENT FILED
- 28 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Aug 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 23 Aug 2025 — NOTICE OF REVIVAL - E-MAILED
- 23 Aug 2025 — PETITION TO REVIVE-GRANTED
- 23 Aug 2025 — TEAS PETITION TO REVIVE RECEIVED
- 07 Apr 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Apr 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED